⚠️ Research Use Only — Compounds discussed are research chemicals, not FDA-approved for human use. Not medical advice. Full disclaimers →
Also known as: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, PNB-0408
Dihexa is a neurotropic peptide research compound (not FDA-approved for human use) studied for synaptogenesis. Dihexa is a brain-penetrating peptide from Washington State University research that triggers new synapse formation at extremely low doses — it's been called millions of times more potent than BDNF for this effect in rodent models. Research dose: 5–20 mcg infrequent (2-3x per week due to long half-life). Half-life: 2 days. Available from COA-verified vendors with code PEPTIDEX for up to 20% off.
Sourcing data for Dihexa is updating.
We verify new listings weekly — check back soon.
Sourcing data for Dihexa is updating.
We verify new listings weekly — check back soon.
Angiotensin IV analog developed at Washington State University. Binds hepatocyte growth factor (HGF) and potentiates its binding to the c-Met receptor, triggering downstream synaptogenesis cascades in
COA-verified vendors · Use code PEPTIDEX for up to 20% off
Verified pricing for Dihexa is not yet available in our database. Browse all COA-verified vendors on our price comparison tool, or check individual vendor pages.
Compare All VendorsAngiotensin IV analog developed at Washington State University. Binds hepatocyte growth factor (HGF) and potentiates its binding to the c-Met receptor, triggering downstream synaptogenesis cascades in hippocampal neurons. Reported to be 7 orders of magnitude more potent than BDNF for synaptic formation in vitro. Crosses blood-brain barrier and is orally bioavailable. Produces dose-dependent improvements in spatial memory in rodent models of cognitive impairment.
McCoy et al. (Journal of Pharmacology & Experimental Therapeutics): Dihexa produces dose-dependent improvements in spatial learning in rodent water maze models and promotes dendritic spine density via HGF/c-Met synaptogenesis signaling.
PreclinicalWright et al.: Establishes the mechanistic basis for angiotensin IV analog activity at HGF and c-Met, demonstrating memory-enhancing and neuroprotective downstream effects.
Preclinical⚠ PRECLINICAL RESEARCH ONLY. No completed human clinical trials. No established human safety profile. Extreme potency suggests very low effective doses but also potential for off-target effects. Do not use without full understanding of preclinical literature.
See our evidence grading methodology for how we evaluate and grade peptide safety data.
* Dosing data from published literature — not a human use recommendation.
Rodent effective doses in the ng/kg range. Human equivalent extrapolations suggest mcg-level doses. No validated human protocol. Oral bioavailability documented in rodents.
Weeks 2–4
Memory and learning improvements in rodent models
| Side Effect | Incidence | Severity |
|---|---|---|
Unknown in humans No human safety data | Not established | rare |
Finding verified, high-purity Dihexa requires rigorous COA verification. We independently evaluate vendors based on third-party HPLC testing, purity thresholds (≥98%), and batch-specific documentation.
View COA-Verified Dihexa✓ Third-party tested·✓ US shipping·✓ COA on every batch
Disclosure: PeptiDex may earn a commission from purchases made through affiliate links. This does not affect our editorial independence or recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
⚠️ Educational only · Not medical advice · For research use only. Information on this page is compiled from peer-reviewed literature and is intended strictly for educational and informational purposes. Peptides discussed may be unapproved research chemicals — consult a licensed healthcare professional before considering any peptide compound. Read our full disclaimer
Affiliate disclosure: PeptiDex may earn commissions from purchases made through vendor links on this page. This does not affect our editorial ranking or vendor recommendations — we exclusively feature vendors that pass independent COA verification. See our methodology · Editorial policy
12stacks • exact dosages • cycle lengths • printable reference
No spam. Unsubscribe anytime.
Independent researcher, not a medical professional
PeptiDex Research is the byline used by the independent researcher who builds and maintains PeptiDex. The site is a one-person research project — there is no editorial board, no medical reviewers, and no clinical staff. Content is produced by reading...
View profile